Kronik Travmatik Ensefalopatinin (CTE) Ortaya Çıkan Semptomatik Tedavisi: bir anlatı incelemesi.
Emerging Symptomatic Treatment of Chronic Traumatic Encephalopathy (CTE): a narrative review.
DOI: 10.1080/14656566.2023.2224501PMID: 37300418
Emerging Symptomatic Treatment of Chronic Traumatic Encephalopathy (CTE): a narrative review.
DOI: 10.1080/14656566.2023.2224501PMID: 37300418
The vicious circle between homocysteine, methyl group-donating vitamins and chronic levodopa intake in Parkinson's disease.
DOI: 10.1007/s00702-023-02666-xPMID: 37329350
Remotely prescribed and monitored home-based gait-and-balance therapeutic exergaming using augmented reality (AR) glasses: protocol for a clinical feasibility study in people with Parkinson’s disease
DOI: 10.21203/rs.3.rs-3035368/v1
EXPERTS II - How are patient and caregiver participation in health and social care shaped by experienced burden of treatment and social inequalities? Protocol for a qualitative synthesis.
DOI: 10.3310/nihropenres.13411.1PMID: 37881470
Intermittent theta-burst stimulation combined with physical therapy as an optimal rehabilitation in Parkinson's disease: study protocol for a randomised, double-blind, controlled trial.
DOI: 10.1186/s13063-023-07425-7PMID: 37328845
Controlled-Release Levodopa for the Treatment of Rapid Motor Fluctuations in Parkinson's Disease Subjects with Subthalamic Nucleus Deep Brain Stimulation.
DOI: 10.1055/s-0043-1769757PMID: 37397033
Repressor Element-1 Binding Transcription Factor (REST) as a Possible Epigenetic Regulator of Neurodegeneration and MicroRNA-Based Therapeutic Strategies.
DOI: 10.1007/s12035-023-03437-1PMID: 37326903
Effect of the Lee Silverman Voice Treatment BIG® on motor symptoms in a participant with progressive supranuclear palsy: A case report.
DOI: 10.1080/09593985.2023.2225588PMID: 37326324
Focused ultrasound thalamotomy for tremor treatment impacts the cerebello-thalamo-cortical network.
DOI: 10.1038/s41531-023-00543-8PMID: 37322044
Therapeutic Potential of Heterocyclic Compounds Targeting Mitochondrial Calcium Homeostasis and Signaling in Alzheimer's Disease and Parkinson's Disease.
DOI: 10.3390/antiox12061282PMID: 37372013
Neuromodulation in Parkinson's disease targeting opioid and cannabinoid receptors, understanding the role of NLRP3 pathway: a novel therapeutic approach.
DOI: 10.1007/s10787-023-01259-0PMID: 37318694
Ferroptosis: A potential therapeutic target in autoimmune disease (Review).
DOI: 10.3892/etm.2023.12067PMID: 37408857
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.